SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the Results of the EMPEROR-Preserved Trial?

Detalles Bibliográficos
Autores principales: Korosoglou, Grigorios, Giusca, Sorin, Kelle, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795365/
https://www.ncbi.nlm.nih.gov/pubmed/35097034
http://dx.doi.org/10.3389/fcvm.2021.822968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795365/
https://www.ncbi.nlm.nih.gov/pubmed/35097034
http://dx.doi.org/10.3389/fcvm.2021.822968

Ejemplares similares